Behcet disease in adult Druzes in north Israel: The influence of ethnic origin on disease expression and severity

Journal of Clinical Rheumatology

Volumn 13, Issue 3, 2007, Pages 124-127

  Rozenbaum, M ^a,b   Boulman, N ^a,b   Slobodin, G ^a,b   Zisman, D ^c   Mader, R ^a,d   Yankevitch, A ^e,f   Weinberger, A ^e,f   Rosner, I ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

^d HAEMEK MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f RABIN MEDICAL CENTER   (Israel)

Author keywords

Arabs; Behcet's disease; Druze; Severity

Indexed keywords

HLA B51 ANTIGEN;

ADULT; AGED; ARAB; ARTHRITIS; ARTICLE; BEHCET DISEASE; BLINDNESS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; DISEASE SEVERITY; ETHNIC GROUP; EYE DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; ISRAEL; MALE; MOUTH DISEASE; PRIORITY JOURNAL; UVEITIS;

ADULT; ARABS; ARTHRITIS; BEHCET SYNDROME; BLINDNESS; ETHNIC GROUPS; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; ISRAEL; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN ULCER; STOMATITIS, APHTHOUS; UVEITIS; VENOUS THROMBOSIS;

EID: 34249982597     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3180645878     Document Type: Article

References (23)

1. Sakane T, Takeno M, Suzuki N, et al. Behcet's disease. N Engl J Med. 1999;341:1284-1289.
2. O'Neill T, Rigby A, McHugh S, et al. Regional differences in clinical manifestations of Behcet's disease. In: Weschler B, Gordeau P, eds. Behcet's Disease: Proceedings of the 6th International Conference on Behcet's Disease. Amsterdam: Excerpta Medica; 1993:159-163.
3. Yazici H, Yurdakul S, Hamuryudan V, et al. Behcet's syndrome. Rheumatology. Vol 2. London: Mosby; 3rd ed. 2003:1665-1669.
4. Davies PG, Fordham JN, Kirwan JR, et al. The pathergy test and Behcet's syndrome in Britain. Ann Rheum Dis. 1984;43:70-73.
5. Zouboulis CC. Epidemiology of Adamantiades-Behcet's disease. Ann Med Interne Paris. 1999;150:488-498.
6. Muhaya M, Lightman S, Ikeda E, et al. Behcet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm. 2000;8:41-48.
7. Rozenbaum M, Marcovici D, Rosner I. FMF in Druzes of north Israel. In: Sohar E, Gafni S, Pras M, eds. Proceedings of the First International Conference on FMF. Jerusalem: Freud Publishing House; 1997:60-61.
8. International Study Group of Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1078-1080.
9. Krause I, Mader R, Sulkes J, et al. Behcet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol. 2001;28:1033-1036.
10. Krause I, Rosen Y, Kaplan I, et al. Recurrent aphthous stomatitis in Behcet's disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med. 1999;28:193-196.
11. Fietta P. Behcet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol. 2005;38:S96-S105.
12. Ahmad T, Wallace GR, James T, et al. Mapping the HLA association in Behcet's. A role for tumor necrosis factor polymorphism? Arthritis Rheum. 2003;48:807-813.
13. Amoura Z, Dode C, Hue S, et al. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behcet's disease. Arthritis Rheum. 2005;52:608-611.
14. Gonzalez-Escribano MF, Morales J, Garcia-Lozano JR, et al. TAP polymorphism in patients with Behcet's disease. Ann Rheum Dis. 1995;54:386-388.
15. Takizowa K, Takeuchi F, Nabeta H, et al. Association of transporter associated with antigen processing genes with Behcet's disease in Japanese. Autoimmunity. 2003;36:161-165.
16. Coskun M, Bacanli A, Sallakci N, et al. Specific interleukin-1 gene polymorphism in Turkish patients with Behcet's disease. Exp Dermatol. 2005;14:124-129.
17. Chen Y, Vaughan RW, Kondeatis E, et al. Chemokine gene polymorphism associate with gender in patients with uveitis. Tissue Antigens. 2004;63:41-45.
18. Salvarani C, Boiardi L, Casali B, et al. Endothelial nitric oxide synthetase gene polymorphism in Behcet's disease. J Rheumatol. 2002;29:535-540.
19. Salvarani C, Boiardi L, Casali B, et al. Vascular endothelial growth factor gene polymorphism in Behcet's disease. J Rheumatol. 2004;31: 1785-1789.
20. Zouboulis CC, Kotter I, Diawari D, et al. Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med J. 1997;38:411-422.
21. Kotter I, Vonthein R, Muller CA, et al. Behcet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol. 2004;31:133-139.
22. Benhamour S, Naji T, Alaoui FZ, et al. Neurological involvement in Behcet's disease. 154 cases from cohort of 925 patients and review of the literature. Rev Neurol (Paris). 2006;11:1084-1090.
23. Imirzalioglu N, Dursun A, Tastan B, et al. MEFV gene is a probable susceptibility gene for Behcet's disease. Scand J Rheumatol. 2005;34:56-58.